Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 132581, 5 pages
http://dx.doi.org/10.1155/2011/132581
Research Article

Effect of One Year of Cryopreservation on the Activity of Lysosomal Hydrolases from EBV-Transformed Lymphocytes

1Postgraduate Program in Biological Sciences and Biochemistry, Department of Biochemistry, Federal University of Rio Grande do Sul, 90035-003 Porto Alegre, RS, Brazil
2Medical Genetics Service, Clinical Hospital of Porto Alegre, 90035-003 Porto Alegre, RS, Brazil

Received 25 November 2010; Revised 15 March 2011; Accepted 23 March 2011

Academic Editor: Ayman El-Kadi

Copyright © 2011 A. S. de Mello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Sinclair, “A new look at the inborn errors of metabolism,” Annals of Clinical Biochemistry, vol. 19, no. 4, pp. 314–321, 1982. View at Google Scholar · View at Scopus
  2. D. A. Wenger, S. Coppola, and S. L. Liu, “Insights into the diagnosis and treatment of lysosomal storage diseases,” Archives of Neurology, vol. 60, no. 3, pp. 322–328, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Minami, Y. Watanabe, and T. Kudoh, “Lysosomal acid hydrolases in established lymphoblastoid cell lines, transformed by Epstein-Barr virus, from patients with genetic lysosomal storage diseases,” Human Genetics, vol. 44, no. 1, pp. 79–87, 1978. View at Google Scholar
  4. J. Elliott, M. B. Coulter-Mackie, J. H. Jung, D. I. Rodenhiser, and S. M. Singh, “A method for transforming lymphocytes from very small blood volumes suitable for paediatric samples,” Human Genetics, vol. 86, no. 6, pp. 615–616, 1991. View at Google Scholar · View at Scopus
  5. A. S. Sun, B. B. Aggarwal, and L. Packer, “Enzyme levels of normal human cells: aging in culture,” Archives of Biochemistry and Biophysics, vol. 170, no. 1, pp. 1–11, 1975. View at Google Scholar · View at Scopus
  6. T. Levade, A. Maret, and R. Salvayre, “Biochemical and ultrastructural studies on an Epstein-Barr virus-transformed lymphoid cell line from a Niemann-Pick disease type C patient,” Biochimica et Biophysica Acta, vol. 877, no. 3, pp. 415–422, 1986. View at Google Scholar
  7. R. Minami, M. Suzuki, and T. Kudoh, “α L iduronidase activity in established lymphoblastoid cells from patients with Hurler and Scheie syndromes transformed by Epstein Barr virus,” Tohoku Journal of Experimental Medicine, vol. 122, pp. 393–396, 1977. View at Google Scholar · View at Scopus
  8. A. Negre, R. Salvayre, and A. Maret, “Lymphoid cell lines as a model system for the study of Wolman's disease: enzymatic, metabolic and ultrastructural investigations,” Journal of Inherited Metabolic Disease, vol. 9, no. 2, pp. 193–201, 1986. View at Google Scholar · View at Scopus
  9. J. C. Niederman, R. W. McCollum, G. Henle, and W. Henle, “Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies,” Journal of the American Medical Association, vol. 203, no. 3, pp. 205–209, 1968. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Takahashi, T. Kawabe, Y. Okazaki et al., “In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus,” DNA and Cell Biology, vol. 22, no. 11, pp. 727–735, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. S. De Mello, F. Provin, K. Michelin-Tireli, M. V. Camelier, and J. C. Coelho, “Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases,” Cell Proliferation, vol. 43, no. 2, pp. 164–169, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Sugimoto, Y. Furuichi, T. Ide, and M. Goto, “Incorrect use of “immortalization” for B-lymphoblastoid cell lines transformed by Epstein-Barr virus,” Journal of Virology, vol. 73, no. 11, pp. 9690–9691, 1999. View at Google Scholar · View at Scopus
  13. S. P. Peters, P. Coyl, and R. H. Glew, “Differentiation of β glucocerebrosidase from β glucosidase in human tissues using sodium taurocholate,” Archives of Biochemistry and Biophysics, vol. 175, no. 2, pp. 569–582, 1976. View at Google Scholar · View at Scopus
  14. J. J. Hopwood, V. Muller, A. Smithson, and N. Bagget, “A fluorometric assay using 4-methylumbelliferyl α-L-iduronide for the estimation of α-L-iduronidase activity and the detection of Hurler and Scheie syndromes,” Clinica Chimica Acta, vol. 92, no. 2, pp. 257–265, 1979. View at Google Scholar · View at Scopus
  15. R. J. Desnick, K. Y. Allen, S. J. Desnick, M. K. Raman, R. W. Bernlohr, and W. Krivit, “Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. α-galactosidase activities in plasma, serum, urine, and leukocytes,” The Journal of Laboratory and Clinical Medicine, vol. 81, no. 2, pp. 157–171, 1973. View at Google Scholar · View at Scopus
  16. Y. Li, C. R. Scott, N. A. Chamoles et al., “Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening,” Clinical Chemistry, vol. 50, no. 10, pp. 1785–1796, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of biological chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  18. A. S. Mello, M. G. Burin, K. Michellin et al., “Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders—enumerative conditions for cryopreservation,” Cell Proliferation, vol. 39, no. 1, pp. 29–36, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. O. Staretz-Chacham, T. C. Lang, M. E. Lamarca, D. Krasnewich, and E. Sidransky, “Lysosomal storage disorders in the newborn,” Pediatrics, vol. 123, no. 4, pp. 1191–1207, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. H. M. Oh, J. M. Oh, S. C. Choi et al., “An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes,” Cell Proliferation, vol. 36, no. 4, pp. 191–197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Bes, R. Salvayre, and T. Levade, “Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B,” Biology of the Cell, vol. 50, no. 3, pp. 299–302, 1984. View at Google Scholar · View at Scopus
  22. A. Maret, R. Salvayre, and A. Negre, “Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: tay-Sachs and Sandhoff diseases,” Biology of the Cell, vol. 53, no. 3, pp. 293–296, 1985. View at Google Scholar · View at Scopus
  23. A. Maret, R. Salvayre, N. Livni, J. Icart, M. Vuillaume, and L. Douste-Blazy, “Biochemical and ultrastructural findings in Epstein-Barr virus-transformed lymphoid cell lines from type 1 Gaucher disease,” Biology of the Cell, vol. 59, no. 1, pp. 101–104, 1987. View at Google Scholar · View at Scopus
  24. D. Catovsky, P. J. Holt, and D. A. Galton, “Binucleated blast-cells in lymphocyte cultures from myelomatosis,” Immunology, vol. 22, no. 6, pp. 1103–1109, 1972. View at Google Scholar · View at Scopus